Top Markets
Coin of the day
Oncoinvent ASA Oncoinvent ASA

Oncoinvent ASA

ONCIN
Rang in aandelen #26813
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Aandeelprijs
$8.39
Marktkapitalisatie
$37.55M
Verandering (1 dag)
-7.83%
Verandering (1 jaar)
-26.06%
Land
NO
Handel Oncoinvent ASA (ONCIN)

Categorie

Koersgeschiedenis voor Oncoinvent ASA (ONCIN)
Hoogste slotkoers: $8.94 op 2026-08-01

Laagste slotkoers: $4.58K op 2017-04-01
Koersgeschiedenis van Oncoinvent ASA van 2017 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 34.81%
2025 -93.86%
2024 -63.90%
2023 -73.76%
2022 -63.83%
2021 -44.23%
2020 73.06%
2019 -30.98%
2018 -3.30%
2017 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$755.89 6.20%
CH